TR199900013T2 - Yeni bile�ikler. - Google Patents

Yeni bile�ikler.

Info

Publication number
TR199900013T2
TR199900013T2 TR1999/00013T TR9900013T TR199900013T2 TR 199900013 T2 TR199900013 T2 TR 199900013T2 TR 1999/00013 T TR1999/00013 T TR 1999/00013T TR 9900013 T TR9900013 T TR 9900013T TR 199900013 T2 TR199900013 T2 TR 199900013T2
Authority
TR
Turkey
Prior art keywords
bracelets
new
formula
medicaments
relate
Prior art date
Application number
TR1999/00013T
Other languages
English (en)
Turkish (tr)
Inventor
Bantick John
Perry Matthew
Thorne Philip
Original Assignee
Astra Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614360.7A external-priority patent/GB9614360D0/en
Priority claimed from GBGB9626884.2A external-priority patent/GB9626884D0/en
Application filed by Astra Pharmaceuticals Ltd. filed Critical Astra Pharmaceuticals Ltd.
Publication of TR199900013T2 publication Critical patent/TR199900013T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TR1999/00013T 1996-07-09 1997-07-04 Yeni bile�ikler. TR199900013T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9614360.7A GB9614360D0 (en) 1996-07-09 1996-07-09 Compounds
GBGB9626884.2A GB9626884D0 (en) 1996-12-24 1996-12-24 Compounds

Publications (1)

Publication Number Publication Date
TR199900013T2 true TR199900013T2 (xx) 1999-04-21

Family

ID=26309668

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00013T TR199900013T2 (xx) 1996-07-09 1997-07-04 Yeni bile�ikler.

Country Status (16)

Country Link
EP (1) EP0915879A1 (cs)
JP (1) JP2000516206A (cs)
KR (1) KR20000023644A (cs)
AR (1) AR008395A1 (cs)
AU (1) AU708882B2 (cs)
BR (1) BR9710215A (cs)
CA (1) CA2260057A1 (cs)
CZ (1) CZ3699A3 (cs)
EE (1) EE9900012A (cs)
ID (1) ID18889A (cs)
IL (1) IL127690A0 (cs)
IS (1) IS4932A (cs)
NO (1) NO990072D0 (cs)
PL (1) PL331090A1 (cs)
TR (1) TR199900013T2 (cs)
WO (1) WO1998001449A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA007933B1 (ru) * 2001-08-13 2007-02-27 Янссен Фармацевтика Н.В. 2,4,5-тризамещенные производные тиазолила и их противовоспалительная активность
KR101822072B1 (ko) 2009-11-24 2018-01-25 노발레드 게엠베하 유기 반도전성 물질을 포함하는 유기 전자 디바이스
JP6067873B2 (ja) * 2012-11-30 2017-01-25 エルジー・ケム・リミテッド 新規な化合物およびそれを用いた有機電子素子
KR102153040B1 (ko) 2013-11-28 2020-09-07 삼성전자주식회사 축합환 화합물 및 이를 포함한 유기 발광 소자
MX2018012831A (es) 2016-04-22 2019-03-28 Vioptix Inc Determinación de saturación absoluta y relativa del oxígeno tisular.
CN108484606B (zh) * 2018-03-16 2020-03-06 江南大学 一种嘧啶并[4,5-f]喹唑啉类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670577A1 (de) * 1967-10-05 1971-05-19 Akad Wissenschaften Ddr Verfahren zur Herstellung von 5-oxo-5.6.7.8-tetrahydro-chinazelinen
US4272535A (en) * 1978-07-31 1981-06-09 Schering Corporation 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents
US4762843A (en) * 1986-09-15 1988-08-09 Warner-Lambert Company Hetero [f] fused carbocyclic pyridines as dopaminergic agents
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists

Also Published As

Publication number Publication date
AR008395A1 (es) 2000-01-19
NO990072D0 (no) 1999-01-08
CZ3699A3 (cs) 1999-06-16
JP2000516206A (ja) 2000-12-05
BR9710215A (pt) 1999-08-10
EP0915879A1 (en) 1999-05-19
KR20000023644A (ko) 2000-04-25
IS4932A (is) 1998-12-23
WO1998001449A1 (en) 1998-01-15
AU3711697A (en) 1998-02-02
CA2260057A1 (en) 1998-01-15
ID18889A (id) 1998-05-20
IL127690A0 (en) 1999-10-28
AU708882B2 (en) 1999-08-12
EE9900012A (et) 1999-06-15
PL331090A1 (en) 1999-06-21

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
SE9604786D0 (sv) New compounds
SE8804629D0 (sv) New therapeutically active compounds
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
CA2216796A1 (en) Quinazoline derivatives
ES2132216T3 (es) Nuevos derivados de amidinas, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
TR200000197T2 (tr) Yeni bileşimler
AP1253A (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate.
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
TR199901433T2 (xx) Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�.
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
SE9802206D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
AU1792700A (en) Compositions for the treatment of skin diseases
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
SE9504662D0 (sv) New compounds
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
TR199900013T2 (xx) Yeni bile�ikler.
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�